In this March 16, 2020 file photo, a subject receives an injection in the first-stage safety study clinical trial of a possible Moderna vaccine for COVID-19, the disease caused by the new coronavirus, in the Kaiser Permanente Washington Health Research Institute in Seattle. Ted S. Warren | AP A Goldman …
Read More »
Moderna’s shares rose 12% on Wednesday after the biotech company released promising data on its potential coronavirus vaccine trial, saying it generated a “robust” immune response. The vaccine candidate produced neutralizing antibodies, which scientists believe is important for developing immunity to the virus, in the 45 patients evaluated in the …
Read More »
A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against coronavirus disease (COVID-19), in Cambridge, Massachusetts, May 18, 2020. Brian Snyder | Reuters Moderna will begin its late-stage trial by testing a possible vaccine to prevent Covid-19 on July 27, according to a publication published Tuesday …
Read More »
The headquarters of the German immunotherapy company BioNTech is located on April 22, 2020 in Mainz, Germany. Thomas Lohnes | fake pictures Look at the companies that make headlines after the bell: Tesla – Tesla shares fell 2% in extended trading. During the day, the shares rose and then fell …
Read More »
Shares rebounded to begin the week after Pfizer and BioNTech’s Covid-19 vaccine candidates received “fast track” status. This is what strategists and portfolio managers say for the coming semester and how investors should prepare. Nela Richardson, director and investment strategist at Edward Jones, sees stocks continue to rise in hopes …
Read More »